Pinnacle Wealth Management Advisory Group LLC Buys 484 Shares of Colgate-Palmolive (NYSE:CL)

Pinnacle Wealth Management Advisory Group LLC raised its stake in shares of Colgate-Palmolive (NYSE:CL) by 4.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,612 shares of the company’s stock after acquiring an additional 484 shares during the period. Pinnacle Wealth Management Advisory Group LLC’s holdings in Colgate-Palmolive were worth $926,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of CL. FMR LLC increased its position in shares of Colgate-Palmolive by 27.3% during the 3rd quarter. FMR LLC now owns 5,597,742 shares of the company’s stock valued at $398,055,000 after purchasing an additional 1,199,660 shares during the last quarter. AEGON ASSET MANAGEMENT UK Plc bought a new stake in Colgate-Palmolive in the fourth quarter worth about $62,728,000. Assenagon Asset Management S.A. boosted its stake in Colgate-Palmolive by 92.2% in the fourth quarter. Assenagon Asset Management S.A. now owns 1,436,054 shares of the company’s stock valued at $114,468,000 after acquiring an additional 688,733 shares during the last quarter. Envestnet Asset Management Inc. grew its position in shares of Colgate-Palmolive by 225.4% during the 3rd quarter. Envestnet Asset Management Inc. now owns 930,072 shares of the company’s stock valued at $66,137,000 after acquiring an additional 644,205 shares during the period. Finally, Bank of Nova Scotia increased its stake in shares of Colgate-Palmolive by 188.5% during the 3rd quarter. Bank of Nova Scotia now owns 883,272 shares of the company’s stock worth $62,809,000 after purchasing an additional 577,114 shares during the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Price Performance

Shares of CL traded down $0.60 during midday trading on Wednesday, reaching $93.48. The stock had a trading volume of 7,252,082 shares, compared to its average volume of 4,695,009. The company’s 50-day moving average is $88.64 and its 200 day moving average is $82.63. The company has a market capitalization of $76.69 billion, a price-to-earnings ratio of 29.58, a price-to-earnings-growth ratio of 3.43 and a beta of 0.40. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $94.40. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 13.21.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. The company had revenue of $5.07 billion during the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The firm’s revenue was up 6.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.73 EPS. On average, equities analysts predict that Colgate-Palmolive will post 3.52 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be issued a $0.50 dividend. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. This represents a $2.00 annualized dividend and a dividend yield of 2.14%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 63.29%.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on CL. Barclays increased their price objective on Colgate-Palmolive from $84.00 to $85.00 and gave the company an “equal weight” rating in a report on Tuesday, April 30th. Raymond James upgraded shares of Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 target price for the company in a research report on Monday, January 29th. Stifel Nicolaus boosted their price target on shares of Colgate-Palmolive from $94.00 to $95.00 and gave the company a “buy” rating in a research report on Monday, April 29th. JPMorgan Chase & Co. raised their price objective on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the stock an “overweight” rating in a report on Thursday, January 18th. Finally, Evercore ISI increased their target price on Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a research report on Monday, April 8th. Three analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $91.44.

Insider Activity at Colgate-Palmolive

In related news, CEO Noel R. Wallace sold 50,000 shares of Colgate-Palmolive stock in a transaction on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the sale, the chief executive officer now owns 274,179 shares in the company, valued at $22,797,983.85. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, CEO Noel R. Wallace sold 50,000 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the transaction, the chief executive officer now owns 274,179 shares in the company, valued at approximately $22,797,983.85. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Jennifer Daniels sold 3,538 shares of the business’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total transaction of $299,562.46. Following the sale, the insider now owns 59,698 shares in the company, valued at approximately $5,054,629.66. The disclosure for this sale can be found here. Insiders have sold a total of 159,048 shares of company stock worth $13,336,846 in the last 90 days. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.